Tony Ince

Advocate for the renewed and long-term funding of the Canada Black Justice Strategy.

BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs. Improve safeguards for Canadian health data. Improve labour mobility so physicians can work across the country. Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada, including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian

HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH PROMOTION AND DISEASE PREVENTION: Increased investments in health and social-determinants-of-health related programs, including measures to address the opioid crisis, mental health and addictions, and the regulation of natural health products. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, the development of a Federal Disability Benefit, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, providing clarity and guidance on federal forms, and advocacy on discontinuing the requirement that employees present sick notes to their employers. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs. Improve safeguards for Canadian health data. Improve labour mobility so physicians can work across the country. Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key s

BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. MEDICAL ASSISTANCE IN DYING: Advancing the medical profession’s perspectives on medical assistance in dying. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. CANADA HEALTH TRANSFER: Increased federal funding for health care to the provinces and territories to ensure the sustainability of the health care system. AGEING WITH DIGNITY: Advocate for a pan-Canadian plan to improve elder care, including investments in long-term care standards, enhanced home and community-based care, and supports for older persons, an older adults care benefit program to deliver funding to older adults and caregivers to cover out of pocket health care costs, improved national standards and investment in the area of palliative and end of life care, and the development of a United Nations document supporting the rights of older persons. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PERSONAL INFORMATION PROTECTION AND ELECTRONIC DOCUMENT ACT (PIPEDA) PRIVACY PROTECTION OF HEALTH INFORMATION AND THE REGULATORY REVIEW: Improvement to privacy legislation to protect the privacy of health information. INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. CANADIAN PHARMACEUTICAL STRATEGY: A national strategy to ensure all Canadian have access to safe, effective and affordable prescription drugs regardless of employment status or geography. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrict

Lobby in support of supply management for dairy.

Lobby federal government to support dairy supply management and defend it at international trade negotiations.

Advocating that the federal government maintain funding where possible and ensure continuity of dairy research and that no negative impacts occur to dairy research as a result of recent funding cuts. Advocating that no concessions impacting dairy or supply management be granted in the context of any negotiations with the U.S. Lobby federal government to support dairy supply management and defend it at international trade negotiations. WTO (World Trade Organization) Negotiations on Agriculture as it relates to supply management. Implementation of Special Agricultural Safeguard for supply-managed products, dairy products in particular. Agreement on Internal Trade - Review of Chapter 9

Seeking funding to provide education and information about Canada's human and physical geography.

Bill S-201, National Framework on Sickle Cell Disease Act, respecting provisions outlined in Section 2, subsections (a), (b), (e), and (i). Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board Innovation, Science and Economic Development Canada Innovation and Skills Strategy and other government policies and programs related to incentivizing research and development activities in Canada. Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries. Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases. Common Drug Review, as it relates to health technology assessments and drug product reimbursement recommendations.

Adoption of Bill S-201, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell disease and increase public awareness of the disease. Implementation of Canada's action plan for pain and federal initiatives related to pain management. Implementation of the the Pharmacare Act and the National Strategy for Drugs for Rare Diseases Implementation of the National Strategy for Drugs for Rare Disease, and other policies or programs related to rare diseases Regulatory amendments and/or guidelines related to the Food and Drugs Act Regulations and Health Canada to implement an orphan drug regulatory framework. Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities and attract investments in Canada, including the Biomanufacturing and Life Sciences Strategy Regulations, guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board Enhancement to Canada's regulatory and funding environment for new medicines, including Health Canada authorizations of medicines and framework for clinical trials, health technology assessment processes, reimbursement negotiations and funding decisions. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.

Les discussions avec les représentant-e-s du gouvernement fédéral visent à influencer les priorités de financement et les programmes d’aide internationale afin de favoriser l’octroi de subventions, contributions ou autres avantages financiers pour les projets du CECI liés aux droits des femmes et des filles, au développement économique durable et à la gouvernance inclusive. Les discussions avec les représentant-e-s du gouvernement fédéral visent à influencer l’élaboration, la mise en œuvre et les priorités des politiques et programmes en matière de coopération internationale, de promotion des droits des femmes et des filles, de développement économique durable et de gouvernance inclusive.

Discussions regarding the application of the Impact Assessment Act to nuclear projects, and the promotion of regulatory effectiveness and efficiency. Discussions regarding the role of nuclear energy in Canada’s climate change policy, including efforts to promote investment in nuclear energy. Advocating for federal support (financial, regulatory and policy) to develop and deploy large/small nuclear and fuel initiatives. International Trade of nuclear technology with respect to nuclear cooperation.

Advancing discussions on programs and contracts tied to the development and support of future combat vessels. Funding to prepare the facility for construction of the future River Class Destroyer fleet and to support the ongoing maintenance of vessels. Interactions with Government officials regarding in-service support for Halifax Class Frigates. Input into the Federal Government's National Shipbuilding Procurement Strategy as it relates to Irving Shipbuilding being selected on October 19, 2011 to build the Combat Vessel work package.

Programmes d'aide internationale en rapport au respect de l'engagement pris par les pays développés de consacrer 0,7% de leur Produit intérieur brut (PIB) à l'aide publique au développement et en lien avec la loi canadienne sur l'aide au développement. Politiques Canadiennes vis-à-vis Haïti, Afghanistan, République Démocratique du Congo, en relation avec la réponse humanitaire et la protection des civiles. Politiques Canadiennes dans le cadre des négociations au sein des Nations Unies sur le Traité international sur le commerce des armes, en relation avec la protection des civiles et le développement durable. Politiques Canadiennes dans le cadre des négociations au sein des Nations Unies sur les changements climatiques, en relation avec le financement pour l'adaptation et mitigation des pays en développement. Politique Canadienne sur allègement de la dette des pays admissibles à l’Initiative des pays pauvres très endettés (IPPTE), en relation avec la lutte contre la pauvreté et l'atteinte des objectifs du Millénaire pour le développement. Entente de contribution auprès du Ministère des Affaires mondiales Canada pour financer des projets bilatéraux de développement, de projets d'aide humanitaire, un programme d'envoi de stagiaires et un programme de coopération volontaire.

AFMC, with its partners, is advocating for changes to Canadian policies (tax and intellectual property) to encourage private sector investment in health and biomedical research, as well as initiatives promoting planetary health. The AFMC calls on the federal government to support the sciences and innovation in health research by making how best to train and sustain Canada's future physician-scientist a key part of the discussions surrounding the new Health Accord AFMC seeks increased funding to enhance educational programming relating to professionalism, aboriginal health needs, public health, end-of-life/palliative care and Francophone minorities projects. AFMC is advocating for programs aimed at helping manage physician workforce issues through specific initiatives in medical education, allocation of residency positions and policies regarding international medical graduates. AFMC is advocating for enhancements and optimization of Canada's health and biomedical research enterprise, focussing specifically on issues relating to clinical trials.